Tokyo, Japan

Keisuke Yamamoto

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keisuke Yamamoto. Retrieved from https://idiyas.com/inventor/keisuke-yamamoto-074adggl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keisuke Yamamoto: Innovator in Anticancer Compounds

Introduction

Keisuke Yamamoto is a prominent inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer activity. With a total of 2 patents to his name, Yamamoto's work is paving the way for advancements in cancer treatment.

Latest Patents

Yamamoto's latest patents focus on a compound having anticancer activity. The patents describe a compound or a pharmaceutically acceptable salt thereof, represented by a specific formula. The compound is designed to target cancer cells effectively, showcasing the potential for innovative treatments in oncology.

Career Highlights

Yamamoto is currently employed at Kyowa Kirin Co., Ltd., a company known for its commitment to developing innovative pharmaceuticals. His work at the company has allowed him to explore new avenues in drug development, particularly in the realm of anticancer therapies.

Collaborations

Throughout his career, Yamamoto has collaborated with notable colleagues, including Kenji Uchida and Ryohei Kawai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Keisuke Yamamoto's contributions to the field of anticancer compounds highlight his dedication to improving healthcare through innovation. His patents represent a significant step forward in the fight against cancer, and his work continues to inspire future advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…